Stay updated on Nivolumab in AML Remission at High Risk Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Remission at High Risk Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.5%
    Check dated 2024-12-14T23:51:34.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the locations where the study is taking place.
    Difference
    3%
    Check dated 2024-12-07T21:30:17.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The website has added new features, while several detailed options for data download and participant information have been removed.
    Difference
    4%
    Check dated 2024-11-23T05:59:12.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Several links related to leukemia and clinical resources have been removed, including those from MedlinePlus and NIH, which may affect access to important health information.
    Difference
    1%
    Check dated 2024-11-16T01:35:14.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with numerous new links added related to leukemia and clinical trials, while the previous version 2.12.1 has been removed.
    Difference
    6%
    Check dated 2024-11-08T19:07:18.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The website has updated its version to v2.12.1, removing the estimated timestamps for 'Results First Posted' and 'Last Update Posted' from the previous version v2.12.0.
    Difference
    0.9%
    Check dated 2024-11-01T11:36:31.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Remission at High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.